News Medical Life Sciences covers new research led by OHSU finding that women vaccinated for COVID-19 have a slightly higher risk for a heavier period after vaccination.

In a Science News story about side effects, Alison Edelman, M.D., says that hormone-based birth control methods that “we have are already safe and effective” for the people cleared to use them.

The Statesman Journal reports that Gov. Tina Kotek is pushing legislation to shore up funding for behavioral health services, including $1.5 million to OHSU for the Behavioral Health Coordination Center. OHSU also previously received federal funding for the center.

KPTV covers experience of a patient left waiting and discharged prematurely from the emergency department at Hillsboro Medical Center last spring.

Skanska signs $111 million contract amendment with OHSU for the university's ongoing hospital expansion project.

The Food and Drug Administration authorizes marketing for new treatment of osteoarthritis of the knee, based on nationwide clinical trials, including at OHSU. Dennis Crawford, M.D., says, “Quite frankly, there hasn’t been a substantial development for the treatment of this ubiquitous disease for more than 50 years."

In a live town hall hosted by KATU-TV, Craigan Usher, M.D., shares clinical insight on the mental health challenges young people are facing today and as practical solutions to improve mental health within our social circles and communities.

In a story about dark spots on the skin, Glam magazine cites OHSU research, noting these localized dark spots are usually caused by sun exposure but are also often a normal aspect of aging.

Alice Cuprill Comas, J.D., is named one of the Portland Business Journal's 2023 Executives of the Year.

David Lee, M.D., and Emilee Taylor, provide comment on the safety of statins for treating hyperlipidemia and heart disease.